Jana Medical Company (TADAWUL:9616)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
15.50
-0.04 (-0.26%)
Aug 14, 2025, 2:47 PM AST

Jana Medical Company Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22
50138--
Enterprise Value
60174--
Last Close Price
15.5042.90--
PS Ratio
1.363.75--
PB Ratio
1.273.51--
P/TBV Ratio
1.273.52--
P/FCF Ratio
9.3725.92--
P/OCF Ratio
9.3525.88--
EV/Sales Ratio
1.654.75--
EV/FCF Ratio
11.3732.77--
Debt / Equity Ratio
0.740.740.920.83
Debt / EBITDA Ratio
--2.583.29
Debt / FCF Ratio
5.475.47--
Asset Turnover
0.450.450.87-
Inventory Turnover
9.199.195.14-
Quick Ratio
1.941.942.011.65
Current Ratio
2.172.172.192.16
Return on Equity (ROE)
-61.32%-61.32%16.19%-
Return on Assets (ROA)
-4.03%-4.03%11.10%-
Return on Capital (ROIC)
-4.75%-4.75%12.47%-
Return on Capital Employed (ROCE)
--29.10%21.60%
Earnings Yield
-46.54%-16.81%--
FCF Yield
10.68%3.86%--
Buyback Yield / Dilution
-3.22%-3.22%-27.82%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.